Aerosil Alternative: Equivalent Fumed Silica Grades and How to Switch

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silica Particle Size Guide: How D50, Mesh and Microns Affect Performance
  • Keywords: quartz powder for ceramics
  • Published: 2026-11-20 03:25:53
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Liu, M. et al. Paclitaxel and quercetin co-loaded functional mesoporous silica nanoparticles overcoming multidrug resistance in breast cancer. Coll. Surf. B Biointerfac. 196, 111284 (2020). Article CAS Google Scholar

Foundry Silica Sand: AFS Grain Fineness, Specifications and Uses

Silica Supplier Europe: Major Producers, Regulations and Sourcing Options
Glass Beads vs Silica Microspheres: Differences and Uses
Dynamic therapy refers to an emerging therapeutic modality in which nanosensitizers are activated in the presence of exogenous stimuli such as light, ultrasound and electric field or endogenous tiny molecules such as H 2 O 2, and sequentially induce the in situ production of toxic free radicals for damaging crucial cellular components (e.g., lipids, proteins or DNA), thus leading to cell apoptosis or necrosis. 400, 401 Typical dynamic therapy strategies contain photosensitizer-mediated PDT, sonosensitizer-mediated SDT, nanocatalyst-mediated CDT and electrodynamic therapy (EDT). 401 In dynamic therapy processes, MSNs are outstanding substrate materials for loading nanosensitizers, and their roles include enhancing nanosensitizer stability, cutting down potential toxicity, supplying a suitable microenvironment for chemical reactions, and acting as a therapeutic nanoplatform to integrate multifunctional components. For example, PDT is an oxygen-dependent therapeutic modality, and its therapeutic efficiency is affected by the oxygen concentration. Nonetheless, the tumor microenvironment or biofilm microenvironment are always characterized with hypoxia. 402, 403, 404 For this reason, the simultaneous integration of some components with oxygen-producing functions, such as catalase, 405, 406 MnO 2, 407, 408 and Pt NPs, 409, 410 into the pores or surfaces of MSNs is expected to enhance the photodynamic performance. Comparable to PDT, SDT is also a non-invasive therapeutic modality and many of sonosensitizers are originated from photosensitizers, 411 such as Mn protoporphyrin-encapsulated biodegradable MSNs for MRI-guided tumor SDT, 412 and IR-780 sonosensitizer-loaded hollow MSNs for SDT of pancreatic cancer. 413 Differently, an extremely unique feature in MSNs-based SDT is that MSNs themselves are potentially effective sonosensitizers with the talent to enhance ultrasound-induced cavitation effect, without the introduction of additional sonosensitizers. 414 The principal reason for this is that MSNs possess big amounts of hydrophobic mesopores that can serve as bubble nucleation seeds in response to low-intensity ultrasound. 415, 416 CDT exploits the sickness microenvironment to activate the Fenton/Fenton-like reaction to produce strongly oxidizing •OH for particular and targeted disease therapy, which is first recommended by Zhang et al. in 2016, 417 and has subsequently attracted much attention from researchers. 418, 419 The efficiency of CDT is closely related to the H 2 O 2 content in the disease microenvironment, so researches have focused on introducing functional factors on MSNs matrix to enhance the content of H 2 O 2 reactants, thus increasing the yield of •OH. In this regard, Li et al. encapsulated both ultra-small CaO 2 and Fe 3 O 4 NPs in dendritic MSNs. In the acidic tumor microenvironment, CaO 2 reacts with H + to produce large amounts of H 2 O 2, leading to the enhancement of Fe 3 O 4 -mediated Fenton reaction. 420 In another study, natural glucose oxidase was used to consume intratumoral glucose while producing additional H 2 O 2 for the subsequent Fenton reaction catalyzed by Fe 3 O 4 NPs. 421 Besides, EDT is an emerging therapeutic approach newly proposed in 2019. 422 In this pioneering work, Pt NPs, assisted by a square-wave alternating current electric field, induced the breakdown of water molecules on their surface to generate cytotoxic •OH, which effectively inhibited tumor cell proliferation and triggered tumor cell apoptosis. 422 Regarding the MSNs-based EDT, Gu et al. designed a Pt/MSNs nanocomplex for the first time and encapsulated DOX into MSNs pore channels, followed by a layer of chitosan to stop the premature drug release. Under the tumor microenvironment and alternating current electric field, the designed MSNs-based nanoplatform effectively removed large-sized tumors (over 500 mm 3 ) while ensuring minimal side influences. This work is the first study to combine EDT and chemotherapy, and it provided new insights into the development of MSNs-based EDT nanoplatforms. 141
Silica as a Toothpaste Abrasive: How It Cleans and How RDA Is Controlled
Clinical trials involving mesoporous silica have been ongoing since 2007, discussing its potential in diverse biomedical applications (Table 3 ). To date, the clinical trials have revealed the safety and good tolerability of silica in human subjects. In 2014, MSNs as oral delivery carriers for boosting the pharmacokinetic profile of drugs with limited aqueous solubility were reported. 500 A silica NPs-lipid hybrid formulation loading with ibuprofen (Lipoceramic-IBU) was prepared. The randomized, double-blind, single-dose oral administration study (20 mg ibuprofen) was conducted on 16 healthy male volunteers. The bioavailability of Lipoceramic-IBU was found to be 1.95 times higher than that of the commercial tablet Nurofen. 500 This result suggested the secure and effective use of silica-based NPs in mimicking food impacts to optimize the oral absorption of drugs with poor water solubility. In another clinical trial consisting of 12 participants in 2016, the bioavailability of ordered MSNs-based fenofibrate formulation raised by 54.1% after a single oral dose, when compared to the commercial formulation Lipanthyl. 39 Owing to the potentially perfect clinical outcomes of silica-based nanocarriers, the pharmacokinetics, safety, and metabolic profile of a hybrid core-shell silica NP (named Cornell dots, C dots) with a diameter of 6 nm functionalized with 124 I, targeting peptide cyclo-(Arg-Gly-Asp-Tyr), and Cy5 ( 124 I-cRGDY-PEG-C' dots) is first conducted in humans utilizing PET imaging and clinical tracer at clinical trials in 2014 (NCT01266096). 58 Results showed the good safety and reproducible PK signatures of C dots with the whole-body clearance half-time of 13-21 h after intravenous administration in patients, which is shorter than 111 In labeled liposomes and 131 I-labeled humanized monoclonal antibody A33. These findings verified the possibility of these NPs for cancer diagnostics in humans. 58 Similarly, 8 nm core-shell silica NPs encapsulated with Cy5.5 in the core and connected with cRGDY on the surface (cRGDY-PEG-Cy5.5-nanoparticles) were used in patients at nanomole doses for sentinel lymph nodes detection of head and neck melanoma at a phase 1/2 human clinical trial. 501 The incredible safety, accuracy, reliability, and high contrast of these particles for visual identification of sentinel lymph nodes are irreplaceable by other available imaging molecules presently, of which phase 2 clinical trial is ongoing and will be finished in 2024 (NCT02106598). Meanwhile, another two clinical trials based on C dots are carried out. In 2018, the 89 Zr-DFO-cRGDY-PEG-Cy5-C' dots tracers were first used in both surgical and non-surgical patients for PET-CT imaging of malignant brain tumors in phase 1 clinical trial (NCT03465618). The distribution and removal profiles from the body of these particles will also be assessed till 2023. In 2019, 64 Cu-NOTA-PSMA-PEG-Cy5.5-C' dots tracer was used in another human phase 1 clinical trial for guiding the surgery of prostate cancer by PET and MRI imaging (NCT04167969).As a nanocomposite with high safety and brilliant photothermal conversion efficiency, the silica-gold NPs have also been shown to be potential therapeutic agents for plasmonic photothermal therapy of atherosclerosis (NCT01270139), 502, 503 and photothermal ablation of tumors (NCT00848042, NCT04240639). 40 In addition, an engineered mesoporous silica (SiPore15) with particle size of 1.1-1.5 μm × 0.2-0.4 μm was developed by Baek et al., and they revealed that such pure synthetic amorphous silica could remarkably decrease long-term blood glucose levels, showing good promise for the treatment of prediabetes (NCT03823027). 504 In other clinical trials, an amorphous silica-containing bioactive scaffold, called Siloss, was used to promote bone regeneration, and could be replaced by natural bone due to its fully resorbable nature (NCT02639572), and the silica-calcium phosphate nanocomposite (SCPC) was developed as graft material for the reconstruction of the volume-deficient alveolar ridges (NCT05317039). In all, these clinical trials reveal the safety and efficacy of MSNs in diverse biomedical application scenarios.
Silica Supplier Korea: Key Producers, Demand Sectors and Import Options
Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Organic-Inorganic Composites, Bionanomaterials & Translational Engineering Laboratory, Beijing Key Laboratory of Bioprocess, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, 100029, Beijing, China Bolong Xu, Shanshan Li & Huiyu Liu

Is Silica Soluble in Water? Solubility of Different Silica Forms Explained

What is silica (SiO₂)?

wood coating matting agent Yang, L. et al. Rod-shape MSN@MoS 2 nanoplatform for FL/MSOT/CT imaging-guided photothermal and photodynamic therapy. Theranostics 9, 3992 (2019). Article CAS PubMed Central PubMed Google Scholar

What is the difference between fumed silica and precipitated silica?

325 mesh silica

What drives silica raw material prices?

how to modify nano silica Germain, M. et al. Delivering the power of nanomedicine to patients today. J. Control. Release 326, 164-171 (2020). Article CAS PubMed Central PubMed Google Scholar

Cite this article: Silica Raw Materials News. "Silicon Dioxide in Supplements: Purpose, Safety and Dosage Limits ." Published 2026-11-20 03:25:53. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.